Current NDC auxiliary source row compounder:3967

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5482
Product Ndc: 26436-5482
Product Ndc Digits: 264365482
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: ACS
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ampotericin/ Chloramphenicol/ Sulfamethoxazole
Dosage Form Name: POWDER
Route Name: AURICULAR (OTIC)
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: AMPHOTERICIN B; SULFAMETHOXAZOLE; CHLORAMPHENICOL
Active Ingredients Info: 60 mg/1 g; 470 mg/1 g; 470 mg/1 g
History Active Ingredients Raw: AMPHOTERICIN B; SULFAMETHOXAZOLE; CHLORAMPHENICOL
History Active Ingredients Info Raw: 60 mg/1 g; 470 mg/1 g; 470 mg/1 g
History Dosage Raw: POWDER
Dea Schedule: [empty]
Package Ndc Raw: 26436-5482-2
Package Ndc: 26436-5482-2
Package Ndc Digits: 2643654822
Package Ndc11: 26436548202
Package Description: 20 g in 1 JAR (26436-5482-2)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3967
Source Row Number: 3967
Source Row Hash: 2a4f2863f6147f40ddeb24adb86b59a21bb5af53a403be0f5fea276ecf36d23b
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "AURICULAR (OTIC)",
    "PRODUCTNDC": "26436-5482",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "AMPHOTERICIN B; SULFAMETHOXAZOLE; CHLORAMPHENICOL",
    "DOSAGEFORMNAME": "POWDER",
    "NDCPACKAGECODE": "26436-5482-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "ACS",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Ampotericin/ Chloramphenicol/ Sulfamethoxazole",
    "PACKAGEDESCRIPTION": "20 g in 1 JAR (26436-5482-2) ",
    "ACTIVEINGREDIENTSINFO": "60 mg/1 g; 470 mg/1 g; 470 mg/1 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3967
Source Row Number: 3967
Status Scope: package
Lookup Ndc: 26436-5482-2
Lookup Ndc Digits: 2643654822
Product Ndc: 26436-5482
Product Ndc Digits: 264365482
Package Ndc: 26436-5482-2
Package Ndc Digits: 2643654822
Package Ndc11: 26436548202
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 2a4f2863f6147f40ddeb24adb86b59a21bb5af53a403be0f5fea276ecf36d23b
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27